So there’s been a number of studies now. So now we have an aggregate across these different studies, more than 100 patients where there have been sort of paired sequencing of CLL, Richter samples, and normal samples. So now we’re able to understand some of the common patterns of clonal evolution that sort of can get you towards that end result of transformation...
So there’s been a number of studies now. So now we have an aggregate across these different studies, more than 100 patients where there have been sort of paired sequencing of CLL, Richter samples, and normal samples. So now we’re able to understand some of the common patterns of clonal evolution that sort of can get you towards that end result of transformation. And obviously not everyone that may have some of the genetic risk factors ends up getting transformation. That’s still only a small subset of patients but we’re being able to understand some of the different genetic patterns that we see as well as some of the different pathways that are just regulated between CLL and Richter cells.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.